| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |